MICHAEL M TARNOW Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL M TARNOW.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL M TARNOW. MICHAEL M TARNOW is Director in CASI Pharmaceuticals, Inc. ($CASI) and Director in Xenon Pharmaceuticals Inc. ($XENE).
Latest Insider Trading Transactions of MICHAEL M TARNOW
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 29 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.76 | 5,144 | 19,341 | 0 | |
Oct 29 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.76 | 5,144 | 19,341 | 0 | |
Oct 29 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 10,288 | 0 | 69,713 | 80 K to 69.7 K (-12.86 %) |
Oct 29 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.76 | 5,144 | 19,341 | 80,001 | 74.9 K to 80 K (+6.87 %) |
Oct 29 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.76 | 5,144 | 19,341 | 74,857 | 69.7 K to 74.9 K (+7.38 %) |
Jun 10 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.52 | 5,144 | 18,107 | 0 | |
Jun 10 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.52 | 5,144 | 18,107 | 69,713 | 64.6 K to 69.7 K (+7.97 %) |
Jun 02 2020 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 13.11 | 10,000 | 131,100 | 10,000 | |
Nov 22 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.51 | 2,057 | 7,220 | 0 | |
Nov 22 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.56 | 5,144 | 18,313 | 0 | |
Nov 22 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 2,057 | 0 | 64,569 | 66.6 K to 64.6 K (-3.09 %) |
Nov 22 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.51 | 2,057 | 7,220 | 66,626 | 64.6 K to 66.6 K (+3.19 %) |
Nov 22 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 5,144 | 0 | 64,569 | 69.7 K to 64.6 K (-7.38 %) |
Nov 22 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.56 | 5,144 | 18,313 | 69,713 | 64.6 K to 69.7 K (+7.97 %) |
Sep 18 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
May 23 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.21 | 2,057 | 6,603 | 0 | |
May 23 2019 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.21 | 2,057 | 6,603 | 64,569 | 62.5 K to 64.6 K (+3.29 %) |
Dec 26 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 5,000 | 0 | 62,512 | 67.5 K to 62.5 K (-7.41 %) |
Jun 22 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.07 | 5,144 | 15,792 | 0 | |
Jun 22 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.66 | 2,057 | 7,529 | 0 | |
Jun 22 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.70 | 5,144 | 19,033 | 0 | |
Jun 22 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.07 | 5,144 | 15,792 | 67,512 | 62.4 K to 67.5 K (+8.25 %) |
Jun 22 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.66 | 2,057 | 7,529 | 62,368 | 60.3 K to 62.4 K (+3.41 %) |
Jun 22 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.70 | 5,144 | 19,033 | 60,311 | 55.2 K to 60.3 K (+9.32 %) |
Jun 05 2018 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 6.20 | 15,000 | 93,000 | 15,000 | |
Jun 20 2017 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.51 | 1,028 | 3,608 | 0 | |
Jun 20 2017 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 1,028 | 0 | 55,167 | 56.2 K to 55.2 K (-1.83 %) |
Jun 20 2017 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.51 | 1,028 | 3,608 | 56,195 | 55.2 K to 56.2 K (+1.86 %) |
Jun 02 2017 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 3.85 | 1,250 | 4,813 | 1,250 | |
Jun 02 2017 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 3.85 | 3,500 | 13,475 | 3,500 | |
Jan 27 2017 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 7,201 | 0 | 55,167 | 62.4 K to 55.2 K (-11.55 %) |
Dec 13 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.21 | 14,403 | 46,234 | 0 | |
Dec 13 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 7,202 | 0 | 62,368 | 69.6 K to 62.4 K (-10.35 %) |
Dec 13 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.21 | 14,403 | 46,234 | 69,570 | 55.2 K to 69.6 K (+26.11 %) |
Jun 03 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 7.38 | 1,250 | 9,225 | 1,250 | |
Jun 03 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 7.38 | 3,500 | 25,830 | 3,500 | |
Apr 29 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 3.35 | 1,543 | 5,169 | 0 | |
Apr 29 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 1,543 | 0 | 55,167 | 56.7 K to 55.2 K (-2.72 %) |
Apr 29 2016 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 3.35 | 1,543 | 5,169 | 56,710 | 55.2 K to 56.7 K (+2.80 %) |
Nov 04 2015 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 5.22 | 5,041 | 26,314 | 0 | |
Nov 04 2015 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Gift | G | 0.00 | 5,041 | 0 | 55,167 | 60.2 K to 55.2 K (-8.37 %) |
Nov 04 2015 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 5.22 | 5,041 | 26,314 | 60,208 | 55.2 K to 60.2 K (+9.14 %) |
Jun 19 2015 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | M | 4.95 | 1,543 | 7,638 | 0 | |
Jun 19 2015 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Buy | M | 4.95 | 1,543 | 7,638 | 55,167 | 53.6 K to 55.2 K (+2.88 %) |
May 06 2015 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 13.48 | 1,028 | 13,857 | 1,028 | |
May 06 2015 | XENE | Xenon Pharmaceutic ... | TARNOW MICHAEL M | Director | Option Exercise | A | 13.48 | 3,086 | 41,599 | 3,086 | |
Jun 06 2008 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 0.64 | 30,000 | 19,200 | 30,000 | |
Jun 06 2008 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.00 | 39,063 | 0 | 115,549 | 76.5 K to 115.5 K (+51.07 %) |
Mar 24 2008 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.70 | 8,601 | 6,021 | 76,486 | 67.9 K to 76.5 K (+12.67 %) |
Mar 24 2008 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.61 | 7,299 | 4,452 | 67,885 | 60.6 K to 67.9 K (+12.05 %) |
Mar 24 2008 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.60 | 9,100 | 5,460 | 60,586 | 51.5 K to 60.6 K (+17.67 %) |
Jun 18 2007 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 1.58 | 30,000 | 47,400 | 30,000 | |
Jun 18 2007 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.00 | 15,823 | 0 | 51,486 | 35.7 K to 51.5 K (+44.37 %) |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 1.56 | 30,000 | 46,800 | 30,000 | |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.00 | 16,025 | 0 | 35,663 | 19.6 K to 35.7 K (+81.60 %) |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 3.10 | 30,000 | 93,000 | 30,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 2.16 | 30,000 | 64,800 | 30,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Page: 1